Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

NCT01503580 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

155

Enrollment

OTHER

Sponsor class

Conditions

Antimuscarinic Drug

Interventions

DRUG: tolterodine, solifenacin

Sponsor

National Taiwan University Hospital